Table 2.
Number and percentages of patients with RRT and AKI according to outcome and targeted temperature management
| A | |||
| All patients (n = 126) | Normothermia (n = 71) | Hypothermia (n = 55) | p value |
| AKI, n (%) | 49 (69) | 24 (44) | 0.004 |
| AKI 1, n (%) | 21 (30) | 11 (20) | |
| AKI 2, n (%) | 8 (11) | 4 (7) | |
| AKI 3, n (%) | 20 (28) | 9 (16) | |
| RRT, n (%) | 14 (20) | 6 (11) | ns |
| B | |||
| Favourable outcome (n = 62) | Normothermia (n = 27) | Hypothermia (n = 35) | p value |
| AKI, n (%) | 14 (52) | 14 (40) | ns |
| AKI 1, n (%) | 5 (19) | 8 (23) | |
| AKI 2, n (%) | 2 (7) | 3 (9) | |
| AKI 3, n (%) | 7 (26) | 3 (9) | |
| RRT, n (%) | 5 (19) | 2 (6) | ns |
| C | |||
| Poor outcome (n = 64) | Normothermia (n = 44) | Hypothermia (n = 20) | p value |
| AKI, n (%) | 35 (80) | 10 (50) | 0.017 |
| AKI 1, n (%) | 16 (36) | 3 (15) | |
| AKI 2, n (%) | 6 (14) | 1 (5) | |
| AKI 3, n (%) | 13 (30) | 6 (30) | |
| RRT, n (%) | 9 (21) | 4 (20) | ns |
Number (and percentages) of patients with continuous renal replacement therapy (RRT) and Acute kidney injury (AKI) stage 1–3 and only stage 3 (Kidney Disease Improving Global Outcomes (KDIGO)) in all patients (A), patients with good (B) and poor (C) neurological outcome treated with mild therapeutic hypothermia or normothermia
ns not significant